AUPQ078799A0 - New use - Google Patents

New use

Info

Publication number
AUPQ078799A0
AUPQ078799A0 AUPQ0787A AUPQ078799A AUPQ078799A0 AU PQ078799 A0 AUPQ078799 A0 AU PQ078799A0 AU PQ0787 A AUPQ0787 A AU PQ0787A AU PQ078799 A AUPQ078799 A AU PQ078799A AU PQ078799 A0 AUPQ078799 A0 AU PQ078799A0
Authority
AU
Australia
Prior art keywords
new use
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ0787A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to AUPQ0787A priority Critical patent/AUPQ078799A0/en
Publication of AUPQ078799A0 publication Critical patent/AUPQ078799A0/en
Priority to JP2001501202A priority patent/JP2003501382A/ja
Priority to PCT/JP2000/003533 priority patent/WO2000074665A2/en
Priority to ES00931634T priority patent/ES2202130T3/es
Priority to EP00931634A priority patent/EP1183028B1/en
Priority to US09/926,700 priority patent/US6489340B1/en
Priority to DE60004044T priority patent/DE60004044T2/de
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
AUPQ0787A 1999-06-04 1999-06-04 New use Abandoned AUPQ078799A0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AUPQ0787A AUPQ078799A0 (en) 1999-06-04 1999-06-04 New use
JP2001501202A JP2003501382A (ja) 1999-06-04 2000-05-31 軟骨形成性分化誘発のためのマクロライド化合物の新規用途
PCT/JP2000/003533 WO2000074665A2 (en) 1999-06-04 2000-05-31 New use of macrolide compounds for inducing chondrogenic differentiation
ES00931634T ES2202130T3 (es) 1999-06-04 2000-05-31 Uso de ciertos compuestos macrolidos para inducir diferenciacion condrogenica.
EP00931634A EP1183028B1 (en) 1999-06-04 2000-05-31 Use of certain macrolide compounds for inducing chondrogenic differentiation
US09/926,700 US6489340B1 (en) 1999-06-04 2000-05-31 Macrolide compounds for inducing chondrogenic differentiation
DE60004044T DE60004044T2 (de) 1999-06-04 2000-05-31 Verwendung bestimmter makrolideverbindungen zur forderung der chondrogendifferenzierung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ0787A AUPQ078799A0 (en) 1999-06-04 1999-06-04 New use

Publications (1)

Publication Number Publication Date
AUPQ078799A0 true AUPQ078799A0 (en) 1999-06-24

Family

ID=3814984

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ0787A Abandoned AUPQ078799A0 (en) 1999-06-04 1999-06-04 New use

Country Status (7)

Country Link
US (1) US6489340B1 (cg-RX-API-DMAC10.html)
EP (1) EP1183028B1 (cg-RX-API-DMAC10.html)
JP (1) JP2003501382A (cg-RX-API-DMAC10.html)
AU (1) AUPQ078799A0 (cg-RX-API-DMAC10.html)
DE (1) DE60004044T2 (cg-RX-API-DMAC10.html)
ES (1) ES2202130T3 (cg-RX-API-DMAC10.html)
WO (1) WO2000074665A2 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
AU2003901023A0 (en) * 2003-03-04 2003-03-20 Fujisawa Pharmaceutical Co., Ltd. New use
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
ITMI20051826A1 (it) * 2005-09-29 2007-03-30 Novachem S A Kit per la somministrazione parenterale di medicamenti
EP2182957A4 (en) * 2007-07-31 2012-07-18 Limerick Biopharma Inc PHOSPHORYLATED PYRONANALOGES AND CORRESPONDING METHODS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE388724T1 (de) * 1998-01-08 2008-03-15 Univ Washington Methoden zur kontrolle der zelldifferenzierung und des zellwachstums durch verwendung eines fusionsproteins und eines wirkstoffes

Also Published As

Publication number Publication date
JP2003501382A (ja) 2003-01-14
US6489340B1 (en) 2002-12-03
WO2000074665A3 (en) 2001-05-17
EP1183028B1 (en) 2003-07-23
WO2000074665A2 (en) 2000-12-14
DE60004044T2 (de) 2004-04-15
ES2202130T3 (es) 2004-04-01
DE60004044D1 (de) 2003-08-28
EP1183028A2 (en) 2002-03-06

Similar Documents

Publication Publication Date Title
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU6734700A (en) Cosmetics
AU4431000A (en) Novel use
AU5967600A (en) Candystraw
AU4115400A (en) Short-circuiter
AU2023701A (en) Sketcher
AU2804600A (en) Arylaminoalkylamides
AU2699800A (en) Organoceramics
AU6098300A (en) Follistatin-3
AU4916900A (en) Benzofuranylsulfonates
AU4561600A (en) Benzofuranylaminoalcohols
AU2669501A (en) New use
AU1901801A (en) Glucofuranoses
AU1915601A (en) Periotome
AU2582200A (en) Windturbine
AU4435300A (en) Hula-hoop
AUPQ462399A0 (en) New use
AU3158701A (en) New use
AU2197301A (en) Microlamp
AU5416100A (en) Retinoscopes
AU1737601A (en) Collectalbum
AU5487300A (en) Benzylpiperazinyl-indolinylethanones
AU7567500A (en) Duckboard
AUPQ324999A0 (en) New use